Clinical trials
Microscopic Polyangiitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Terminated | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 8 |
| University of South Florida | 5 |
| Mayo Clinic | 2 |
| Novartis Pharmaceuticals | 2 |
| Alpine Immune Sciences, Inc. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Genentech, Inc. | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| InflaRx GmbH | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Microscopic Polyangiitis | 29 |
| Granulomatosis with Polyangiitis | 28 |
| Churg-Strauss Syndrome | 14 |
| Vasculitis | 14 |
| Polyarteritis Nodosa | 13 |
| Takayasu Arteritis | 12 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 10 |
| Giant Cell Arteritis | 10 |
| IgA Vasculitis | 8 |
| Behcet Syndrome | 7 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.